Price T Rowe Associates Inc. MD grew its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 517.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,529,477 shares of the medical device company's stock after purchasing an additional 2,957,421 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 1.77% of Cooper Companies worth $324,466,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently modified their holdings of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in Cooper Companies in the fourth quarter worth $691,000. Highland Capital Management LLC purchased a new position in Cooper Companies in the 4th quarter worth about $4,004,000. Caprock Group LLC bought a new stake in Cooper Companies during the 4th quarter valued at about $282,000. Franklin Resources Inc. lifted its holdings in Cooper Companies by 194.0% during the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company's stock valued at $5,265,000 after buying an additional 32,260 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its position in Cooper Companies by 6.6% in the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company's stock valued at $26,295,000 after buying an additional 14,687 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the company. Piper Sandler reiterated an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Citigroup dropped their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Finally, Stifel Nicolaus reduced their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and an average target price of $110.25.
Read Our Latest Analysis on Cooper Companies
Cooper Companies Stock Performance
Cooper Companies stock traded down $0.91 during trading hours on Thursday, hitting $80.76. 380,002 shares of the stock traded hands, compared to its average volume of 1,421,804. The firm's 50 day moving average price is $81.78 and its 200-day moving average price is $92.27. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The stock has a market capitalization of $16.15 billion, a price-to-earnings ratio of 41.41, a P/E/G ratio of 2.25 and a beta of 1.01. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38.
Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.
Cooper Companies Profile
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
See Also
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
